000403

Pacific Shuanglin Bio-pharmacy
000403

Last Price

Pacific Shuanglin Bio-pharmacy Earnings Call Summary

Pacific Shuanglin Bio-pharmacy Earnings

Estimates
Actual
Y-on-Y Change
Revenue
EPS

Transcripts

gainify

Events

About Pacific Shuanglin Bio-pharmacy Co., LTD

gainify
000403

Pacific Shuanglin Bio-pharmacy Co., LTD

000403

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), hepatitis B human immunoglobulin, ...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Rong, Xiankui

Employees

2,635

IPO Date

2013-02-08

Headquarters

Sunshine City Global Financial Center, Room 3004, No. 8, Changxing South Street, Jinyuan District, Taiyuan, Shanxi Province, 030000, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.